Treatment of malignant gliomas in the elderly

Journal of Neuro-Oncology

Volumn 43, Issue 2, 1999, Pages 187-193

  Pierga, Jean Yves ^a,b   Hoang Xuan, Khé ^a   Feuvret, Loïc ^a   Simon, Jean Marc ^a   Cornu, Philippe ^a   Baillet, François ^a   Mazeron, Jean Jacques ^a   Delattre, Jean Yves ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT CURIE   (France)

Author keywords

Chemotherapy; Elderly; Malignant gliomas; Radiotherapy

Indexed keywords

CARMUSTINE; LOMUSTINE; NITROSOUREA; PROCARBAZINE; VINCRISTINE;

AGED; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; PROGNOSIS;

AGED; BIOPSY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; GLIOMA; HUMANS; MALE; PROGNOSIS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032869552     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006262918694     Document Type: Article

References (38)

1. Fernandez PM, Brem S: Malignant brain tumors in the elderly. Clin Geriatr Med 13: 327-338, 1997
2. Brandes A, Fiorentino MV: Treatment of high-grade gliomas in the elderly. Oncology 55: 1-6, 1998
3. Davis DL, Hoel D, Fox J, Lopez A: International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 336: 474-481, 1990
4. Annegers F, Schoenberg BS, Okasaki H, Kurland LT: Epidemiologic study of primary intracranial neoplasms. Arch Neurol 38: 217-219, 1981
5. Mao Y, Desmeules M, Semenciw RM, Hill G, Gaudette L, Wigle DT: Increasing brain cancer rates in Canada. Can Med Assoc J 145: 1583-1590, 1991
6. Greig NH, Ries LG, Yancik R, Rapoport SI: Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82: 1621-1624, 1990
7. Helseth A, Mork SJ: Neoplasms of the central nervous system in Norway III. Epidemiological characteristics of intracranial gliomas according to histology. APMIS 97: 547-555, 1989
8. Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry-Amar M, Raverdy N, Schaffer P, Poisson M, Delattre JY: Descriptive epidemiology of cerebral gliomas in France. Cancer 79: 1195-1202, 1997
9. Faliu B, Berthier F, Grosclaude P, Aptel I, Cayla F, Machelard-Roumagnac M, Duchene Y: Prevalence of cancer, health care and daily life assistance in people aged 75 or over living in the Tarn area (France). Bull Cancer 84: 169-174, 1997
10. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff Jd, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
11. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
12. Kallio M, Sankila R Jääsleläinene J, Karjalainen S, Hakulinen T: A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer 68: 1394-1400, 1991
13. Cascinu S, Del Ferro E, Catalano G: Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer. Am J Clin Oncol 19: 371-374, 1996
14. Macdonald DR, Cascino TL, Schold SC, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
16. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617-1625, 1987
17. Simpson JR, Horton JCS, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF: Influence of location and extent of surgical resection on survival of patients with glioma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26: 239-244, 1993
18. Sheline GE: Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys 18: 793-803, 1990
19. Salcman M: Brain tumors and the geriatric patient. J Am Geriatr Soc 30: 501-508, 1982
20. Meckling S, Dold O, Forsyth PAJ, Brasher P, Hagen NA: Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47: 901-905, 1996
21. Tomita T, Raimondi AJ: Brain tumors and the elderly. JAMA 246: 53-55, 1981
22. Kelly PJ, Hunt C: The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery: 62-67, 1994
23. Whittle IR, Denholm SW, Gregor A: Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. Surg Neurol 36: 107-111, 1991
24. Peschel RE, Wilson L, Haffty B, Papadopoulos D, Rosenzweig K, Feltes M: The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. Int J Radiat Oncol Biol Phys 26: 539-544, 1993
25. Walker MD, Strike T, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725-1731, 1979
26. Newall J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J Neurooncol 6: 325-327, 1988
27. Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG: A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29: 835-839, 1994
28. Hoegler DB, Davey P: A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 33: 201-204, 1997
29. Sheline GE, Wara WM, Smith V: Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215-1228, 1980
30. Vigliani MC, Sichez N, Poisson M, Delattre JY: A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: a-4 years results. Int J Radiat Oncol Biol Phys 35: 527-533, 1996
31. Giovanazzi-Bannon S, Rademaker A, Lai G, Benson III AB: Treatment tolerance of elderly cancer patients entered into phase II clinical trials: an Illinois Cancer Center Study. J Clin Oncol 12: 2447-2452, 1994
32. Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L: Age influences chemotherapy response in astrocytomas. Neurology 45: 929-933, 1995
33. Gilbert MR, Bozik M, Armstrong TS, Minhas TA, Lunsford LD, Kondziolka D, Flickinger J: Aggressive chemotherapy treatment of brain tumors in the elderly: results from a phase II study. Proc Am Soc Clin Oncol 15: 152, 1996
34. Zampieri P, Faggin R, Rigon A, Brandes A, Baiocchi C, Gardiman M, Amista P, Minicuci N: Malignant cerebral gliomas in the elderly. J Neurooncol 30: 155, 1996
35. Aaronson N, Ahmedzai S, Bergman B, Bullinger B, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB: The European Organization for Research and Treatment of Cancer QLQ C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376, 1993
36. Shipper H, Clinch J, McMurray A, Lewitt M: Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 2: 472-482, 1984
37. Aiken RD: Quality-of-life issues in patients with malignant gliomas. Sem Oncol 21: 273-275, 1994
38. Ampil F, Fowler M, Kim K: Intracranial astrocytoma in elderly patients. J Neurooncol 12: 125-130, 1992